INS and Glucose intolerance: More importantly, challenging mice with an HF diet after pre-treatment with a CB receptor agonist exacerbated glucose intolerance, stimulated inflammation and increased muscle lipid content, whereas pre-treatment with LPS affected the levels of inflammation and insulin secretion but not the glucose tolerance or the lipid metabolism.